572
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Controlled and uncontrolled allergic asthma in routine respiratory specialist care – a clinical–epidemiological study in Germany

, , , , , , , & show all
Pages 1835-1847 | Accepted 18 Jul 2011, Published online: 09 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Milan Terl, Petr Pohunek, Matyas Kuhn & Jaromir Bystron. (2020) Four seasons of Czech asthma study: asthma characteristics and management reality in the Czech Republic. Journal of Asthma 57:8, pages 898-910.
Read now

Articles from other publishers (9)

Margot L. Salsman, Hannah O. Nordberg, Hans-Ulrich Wittchen, Jens Klotsche, Stephan Mühlig, Oliver Riedel & Thomas Ritz. (2021) Extrapulmonary symptoms of patients with asthma treated in specialist pulmonary care. Journal of Psychosomatic Research 148, pages 110538.
Crossref
Ann-Kathrin Richter, Ludger Klimek, Hans F. Merk, Norbert Mülleneisen, Harald Renz, Wolfgang Wehrmann, Thomas Werfel, Eckard Hamelmann, Uwe Siebert, Gaby Sroczynski, Jürgen Wasem & Janine Biermann-Stallwitz. (2018) Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach. The European Journal of Health Economics 19:9, pages 1229-1242.
Crossref
Vanessa L. Clark, Peter G. Gibson, Grayson Genn, Sarah A. Hiles, Ian D. Pavord & Vanessa M. McDonald. (2017) Multidimensional assessment of severe asthma: A systematic review and meta-analysis. Respirology 22:7, pages 1262-1275.
Crossref
Åse Björstad, Lars-Olaf Cardell, Julie Hahn-Pedersen & Mikael Svärd. (2017) A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting. Clinical Drug Investigation 37:6, pages 541-549.
Crossref
P. G. Gibson, H. Reddel, V. M. McDonald, G. Marks, C. Jenkins, A. Gillman, J. Upham, M. Sutherland, J. Rimmer, F. Thien, G. P. Katsoulotos, M. Cook, I. Yang, C. Katelaris, S. Bowler, D. Langton, P. Robinson, C. Wright, V. Yozghatlian, S. Burgess, P. Sivakumaran, A. Jaffe, J. Bowden, P. A. B. Wark, K. Y. Yan, V. Kritikos, M. Peters, M. Hew, A. Aminazad, M. Bint & M. Guo. (2016) Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry. Internal Medicine Journal 46:9, pages 1054-1062.
Crossref
Thomas Ritz, Hans-Ulrich Wittchen, Jens Klotsche, Stephan Mühlig & Oliver Riedel. (2016) Asthma Trigger Reports Are Associated with Low Quality of Life, Exacerbations, and Emergency Treatments. Annals of the American Thoracic Society 13:2, pages 204-211.
Crossref
Anna von Bülow, Margit Kriegbaum, Vibeke Backer & Celeste Porsbjerg. (2014) The Prevalence of Severe Asthma and Low Asthma Control Among Danish Adults. The Journal of Allergy and Clinical Immunology: In Practice 2:6, pages 759-767.e2.
Crossref
R. D. Goodwin, M. Robinson, P. D. Sly, I. W. McKeague, E. S. Susser, S. R. Zubrick, F. J. Stanley & E. Mattes. (2012) Severity and persistence of asthma and mental health: a birth cohort study. Psychological Medicine 43:6, pages 1313-1322.
Crossref
H.-U. Wittchen, S. Mühlig, J. Klotsche, R. Buhl, P. Kardos, T. Ritz & O. Riedel. (2012) Omalizumab versus Usual Care: Results from a Naturalistic Longitudinal Study in Routine Care. International Archives of Allergy and Immunology 159:1, pages 83-93.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.